Annual Debt To Equity
0.03
-0.01-25.00%
31 December 2023
Summary:
Sunshine Biopharma annual debt to equity ratio is currently 0.03, with the most recent change of -0.01 (-25.00%) on 31 December 2023. During the last 3 years, it has risen by +2.03 (+101.50%). SBFMW annual debt to equity is now -99.67% below its all-time high of 8.98, reached on 31 December 2021.SBFMW Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Debt To Equity
0.02
0.000.00%
30 September 2024
Summary:
Sunshine Biopharma quarterly debt to equity ratio is currently 0.02, unchanged on 30 September 2024. Over the past year, it has dropped by -0.01 (-33.33%). SBFMW quarterly debt to equity is now -99.90% below its all-time high of 20.39, reached on 30 September 2018.SBFMW Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SBFMW Debt To Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -25.0% | -33.3% |
3 y3 years | +101.5% | +100.7% |
5 y5 years | +100.2% | +102.0% |
SBFMW Debt To Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -99.7% | +101.5% | -99.8% | +100.7% |
5 y | 5 years | -99.7% | +100.2% | -99.8% | +100.7% |
alltime | all time | -99.7% | +100.2% | -99.9% | +100.1% |
Sunshine Biopharma Debt To Equity History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | 0.02(0.0%) |
June 2024 | - | 0.02(0.0%) |
Mar 2024 | - | 0.02(-33.3%) |
Dec 2023 | 0.03(-25.0%) | 0.03(0.0%) |
Sept 2023 | - | 0.03(0.0%) |
June 2023 | - | 0.03(-25.0%) |
Mar 2023 | - | 0.04(-80.0%) |
Dec 2022 | 0.04(-99.6%) | 0.20(-97.8%) |
Dec 2021 | 8.98(-549.0%) | 8.98(-398.3%) |
Sept 2021 | - | -3.01(+3.8%) |
June 2021 | - | -2.90(+14.6%) |
Mar 2021 | - | -2.53(+26.5%) |
Dec 2020 | -2.00(+106.2%) | -2.00(+9.3%) |
Sept 2020 | - | -1.83(+77.7%) |
June 2020 | - | -1.03(+13.2%) |
Mar 2020 | - | -0.91(-6.2%) |
Dec 2019 | -0.97(-94.3%) | -0.97(-4.0%) |
Sept 2019 | - | -1.01(+6.3%) |
June 2019 | - | -0.95(-83.8%) |
Mar 2019 | - | -5.85(-65.8%) |
Dec 2018 | -17.09(+1120.7%) | -17.09(-183.8%) |
Sept 2018 | - | 20.39(-542.3%) |
June 2018 | - | -4.61(+68.9%) |
Mar 2018 | - | -2.73(+95.0%) |
Dec 2017 | -1.40(+23.9%) | -1.40(-16.2%) |
Sept 2017 | - | -1.67(+153.0%) |
June 2017 | - | -0.66(-32.7%) |
Mar 2017 | - | -0.98(-13.3%) |
Dec 2016 | -1.13(-40.8%) | -1.13(-246.8%) |
Sept 2016 | - | 0.77(-230.5%) |
June 2016 | - | -0.59(-81.0%) |
Mar 2016 | - | -3.11(+62.8%) |
Dec 2015 | -1.91 | -1.91(+51.6%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2015 | - | -1.26(-14.3%) |
June 2015 | - | -1.47(+8.1%) |
Mar 2015 | - | -1.36(+9.7%) |
Dec 2014 | -1.24(-23.5%) | -1.24(-13.3%) |
Sept 2014 | - | -1.43(+70.2%) |
June 2014 | - | -0.84(-28.2%) |
Mar 2014 | - | -1.17(-27.8%) |
Dec 2013 | -1.62(-282.0%) | -1.62(-723.1%) |
Sept 2013 | - | 0.26(+188.9%) |
June 2013 | - | 0.09(+80.0%) |
Mar 2013 | - | 0.05(-94.4%) |
Dec 2012 | 0.89(>+9900.0%) | 0.89(+1680.0%) |
Sept 2012 | - | 0.05(-68.8%) |
June 2012 | - | 0.16(-20.0%) |
Mar 2012 | - | 0.20(>+9900.0%) |
Dec 2011 | 0.00(0.0%) | 0.00(0.0%) |
Sept 2011 | - | 0.00(0.0%) |
June 2011 | - | 0.00(0.0%) |
Mar 2011 | - | 0.00(0.0%) |
Dec 2010 | 0.00(0.0%) | 0.00(0.0%) |
Sept 2010 | - | 0.00(0.0%) |
June 2010 | - | 0.00(0.0%) |
Mar 2010 | - | 0.00(0.0%) |
Dec 2009 | 0.00(-100.0%) | - |
Oct 2009 | - | 0.00(-100.0%) |
July 2009 | - | -0.73(-6.4%) |
Apr 2009 | - | -0.78(0.0%) |
Jan 2009 | - | -0.78(-14.3%) |
Oct 2008 | - | -0.91(-5.2%) |
July 2008 | -0.96(<-9900.0%) | -0.96(-14.3%) |
Apr 2008 | - | -1.12(<-9900.0%) |
Jan 2008 | - | 0.00(0.0%) |
Oct 2007 | - | 0.00 |
July 2007 | 0.00 | - |
FAQ
- What is Sunshine Biopharma annual debt to equity ratio?
- What is the all time high annual debt to equity for Sunshine Biopharma?
- What is Sunshine Biopharma annual debt to equity year-on-year change?
- What is Sunshine Biopharma quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly debt to equity year-on-year change?
What is Sunshine Biopharma annual debt to equity ratio?
The current annual debt to equity of SBFMW is 0.03
What is the all time high annual debt to equity for Sunshine Biopharma?
Sunshine Biopharma all-time high annual debt to equity ratio is 8.98
What is Sunshine Biopharma annual debt to equity year-on-year change?
Over the past year, SBFMW annual debt to equity ratio has changed by -0.01 (-25.00%)
What is Sunshine Biopharma quarterly debt to equity ratio?
The current quarterly debt to equity of SBFMW is 0.02
What is the all time high quarterly debt to equity for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly debt to equity ratio is 20.39
What is Sunshine Biopharma quarterly debt to equity year-on-year change?
Over the past year, SBFMW quarterly debt to equity ratio has changed by -0.01 (-33.33%)